In the SURMOUNT-1 obesity trial, tirzepatide produced mean weight reductions of roughly 1521% depending on dose over 72 weeks ( Jastreboff et al., NEJM 2022
doi: 10.1038/s41392-023-01367-x 11 RaisRLembergKMTenoraLArwoodMLPalAAltJet al
This study included 90 patients diagnosed with chronic hepatitis B, who were randomly divided into two groups (observation group and control group) using a random number table, with 45 patients in each group
Contact your healthcare provider if pain is severe, symptoms are worsening, or you notice spreading redness, significant swelling, drainage, fever, or another unexpected reaction
Using a clean, tested product ensures you aren't consuming unnecessary fillers or additives that can hinder your progress
With medications Blood thinners (warfarin, aspirin) - May increase bruising at injection sites